Safety of TofAcitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA)- Cardiovascular Endpoints
Inclusion & Exclusion Criteria codes
PRIME is a program of Division of Phamacoepidemiology & Pharmacoeconomics
|
Proudly powered by Weebly